Results 91 to 100 of about 165,756 (267)
Although South Africa was the first country to register and roll out oral pre-exposure prophylaxis (PrEP) biomedical human immunodeficiency virus (HIV) prevention intervention in sub-Saharan Africa (SSA), its uptake remains low, particularly among ...
Lerato Lucia Olifant +2 more
doaj +1 more source
Essential work, invisible workers: The role of digital curation in COVID‐19 Open Science
Abstract In this paper, we examine the role digital curation practices and practitioners played in facilitating open science (OS) initiatives amid the COVID‐19 pandemic. In Summer 2023, we conducted a content analysis of available information regarding 50 OS initiatives that emerged—or substantially shifted their focus—between 2020 and 2022 to address ...
Irene V. Pasquetto +2 more
wiley +1 more source
From the memories of training as a medical student, the report of a patient, an octogenarian woman, black, small, skinny, very lively and communicative. She was happy to tell us, at the instigation of the neurology professor, what had happened to her during the Spanish in Porto Alegre.
openaire +2 more sources
Aims This study aimed to analyse changes in the utilization, expenditure and average cost of noninsulin glucose‐lowering drugs (GLDs) between 2008 and 2023. Methods This was a retrospective observational study of 2008–2023 data from the National Medicaid State Drug Utilization database.
Rawan O. Almadfaa
wiley +1 more source
Introduction This study aimed to estimate the prevalence and associated factors of non-communicable diseases (NCDs) multimorbidity among adults in Morocco.
Karl Peltzer +2 more
doaj +1 more source
Zuranolone: A case study in (regulatory) rush to judgement?
Abstract Sage, in collaboration with Biogen, submitted a new drug approval for zuranolone for postpartum depression (PPD) and major depressive disorder (MDD) in December 2022. In August 2023, the US Food and Drug Administration granted approval for PPD but denied approval for MDD.
Lisa Cosgrove +4 more
wiley +1 more source
Regulators use expedited approval pathways to speed market approval and patient access to promising new drugs. However, there is uncertainty about whether these pathways are successful in approving drugs with significant therapeutic advantages. This systematic review aims to examine the safety, effectiveness and cost‐effectiveness of drugs approved via
Ashleigh Hooimeyer +4 more
wiley +1 more source
Aim This study aimed to compare how Norwegian healthcare professionals (HCPs) and consumers reported the same adverse event (AE) following immunization with vaccines against COVID‐19 during the COVID‐19 pandemic. Specifically, we aimed to compare the extent to which HCPs and consumers reported information relevant for assessing the causal relationship ...
Tommy Emil Dzus +4 more
wiley +1 more source
BackgroundThe human immunodeficiency virus (HIV) remains one of the leading causes of death globally, with South Africa bearing a significant burden. As an effective way of reducing HIV transmission, HIV testing interventions are crucial and require the ...
Musa Jaiteh +3 more
doaj +1 more source

